Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years

@inproceedings{Puthanakit2016RandomizedOT,
  title={Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years},
  author={Thanyawee Puthanakit and Li-Min Huang and Cheng-Hsun Chiu and Renbing Tang and Tino F Schwarz and Susanna Esposito and Louise Frenette and Carlo Giaquinto and Shelly A McNeil and Paul Rheault and Paolo Durando and Matthias Horn and Maximilian Klar and Sylviane Poncelet and St{\'e}phanie De Simoni and Damien Friel and Benoit De Muynck and Pemmaraju Venkata Suryakiran and Marjan Hezareh and Dominique Descamps and Florence Thomas and Frank Struyf},
  booktitle={The Journal of infectious diseases},
  year={2016}
}
BACKGROUND This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9-14 years with one including 3 doses (3D) in women aged 15-25 years. METHODS Girls aged 9-14 years were randomized to receive 2D at months 0 and 6 (M0,6; (n = 550) or months 0 and 12 (M0,12; n = 415), and women aged 15-25 years received 3D at months 0, 1, and 6 (n = 482). End points included noninferiority of HPV-16/18 antibodies by enzyme… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Vaccination programs for older adults in an era of demographic change

T. Mark Doherty, Mark P. Connolly, +11 authors Alberta Di Pasquale
  • European Geriatric Medicine
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Current status and future prospects for human papillomavirus vaccines

  • Archives of pharmacal research
  • 2017
VIEW 2 EXCERPTS
CITES RESULTS

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES